Share This Page
Drug Price Trends for NDC 50268-0682
✉ Email this page to a colleague
Average Pharmacy Cost for 50268-0682
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 50268-0682
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| PRAMOXINE HCL 1% LOTION | AvKare, LLC | 50268-0682-15 | 237ML | 15.85 | 0.06688 | 2023-06-15 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
50268-0682 Market Analysis and Financial Projection
Market Analysis and Price Projections for the Drug NDC: 50268-0682
Understanding the NDC Directory
To analyze the market and price projections for a specific drug identified by its National Drug Code (NDC), it is essential to understand what the FDA's National Drug Code Directory provides. The NDC Directory contains comprehensive information on finished, unfinished, and compounded drug products, including their NDC numbers, product types, non-proprietary names, dosage forms, routes of administration, and marketing dates[1][2][4].
Identifying the Drug
The NDC 50268-0682 is a unique identifier for a specific drug product. To proceed with the analysis, one must first identify the drug associated with this NDC.
Using the NDC Directory
- Access the FDA's National Drug Code Directory to find the proprietary name, non-proprietary name, and other relevant details of the drug associated with NDC 50268-0682.
- The directory will provide information such as the labeler, product code, and package code, which are crucial for identifying the drug[1][4].
Market Research
Competitive Landscape
- Conduct market research to understand the competitive landscape of the therapeutic class in which the drug belongs.
- Identify key competitors, their market share, and the pricing strategies they employ.
- For example, if the drug is in the oncology segment, analyze how it compares to other drugs like Keytruda, Opdivo, and Tecentriq, which are projected to achieve blockbuster status by 2025[2].
Patient Demand
- Assess patient demand and the prevalence of the condition the drug treats.
- This can be done by analyzing epidemiological data and market reports to understand the potential market size.
Regulatory Environment
- Examine the regulatory environment and any recent or upcoming changes that could impact the drug's market position.
- For instance, changes in FDA regulations or the approval of new drugs in the same therapeutic class can significantly affect market dynamics[1][4].
Pricing Trends
Historical Pricing
- Analyze the historical pricing trends of the drug and similar drugs in the same therapeutic class.
- Use data from sources like the Missouri Specialty MAC list or other pricing databases to understand how prices have evolved over time[5].
Cross-Geographic Comparison
- Compare the prices of the drug in different regions, noting that prices in the U.S. are often significantly higher than in other OECD countries or the rest of the world. For example, by 2022, prices in the U.S. were 5.5 times those in the OECD (excluding the U.S.) and 7.7 times prices in the rest of the world (excluding the U.S.)[3].
Forecasting
Market Projections
- Use historical data and market trends to forecast future prices.
- Consider factors such as competition, regulatory changes, economic conditions, and the introduction of generic versions.
- For instance, the sales of generic versions of drugs can impact the overall market size, but this may not be significant until 2025 for certain therapeutic classes[2][3].
Economic Factors
- Take into account economic factors such as inflation, healthcare policy changes, and reimbursement rates.
- These factors can influence the pricing power of pharmaceutical companies and the affordability of the drug for patients.
Example Analysis
Case Study: Immunotherapies
If the drug associated with NDC 50268-0682 is an immunotherapy, such as those used in the treatment of non-small cell lung cancer (NSCLC), the following analysis could be relevant:
- Market Size: The NSCLC market is expected to remain lucrative due to the efficacy of immunotherapies and the lack of significant generic competition until 2025.
- Pricing: The prices of immunotherapies are expected to remain high. For example, Keytruda is projected to contribute $5.2 billion in sales by 2025, with a moderate Compound Annual Growth Rate (CAGR)[2].
Key Considerations
Generic Impact
- The impact of generic versions on the market size and pricing of the drug.
- While generic versions may grow in sales, they are unlikely to significantly impact the overall market size until 2025 for certain therapeutic classes[2].
Regulatory Exemptions
- If the drug is produced by an outsourcing facility, it may be exempt from certain approval requirements under Section 503B of the FD&C Act. This could affect its pricing and market positioning[1].
Price Projections
Short-Term Projections
- Based on current market trends and the absence of significant generic competition, the price of the drug associated with NDC 50268-0682 is likely to remain stable or increase slightly in the short term.
Long-Term Projections
- In the long term, the introduction of new drugs or significant changes in regulatory policies could impact pricing. However, given the current market dynamics, it is reasonable to expect that the drug will maintain its market position and pricing power.
Conclusion
The market analysis and price projections for the drug associated with NDC 50268-0682 depend on a thorough understanding of the competitive landscape, patient demand, regulatory environment, and historical pricing trends. By analyzing these factors and considering economic and regulatory changes, one can make informed projections about the drug's future market performance.
Key Takeaways
- NDC Directory: The FDA's National Drug Code Directory is a critical resource for identifying and analyzing drug products.
- Market Research: Understanding the competitive landscape, patient demand, and regulatory environment is essential for market analysis.
- Pricing Trends: Historical pricing trends and cross-geographic comparisons are vital for forecasting future prices.
- Forecasting: Consider multiple factors including competition, regulatory changes, and economic conditions.
- Generic Impact: The introduction of generic versions can impact market size and pricing but may not be significant until 2025 for certain therapeutic classes.
FAQs
What is the National Drug Code (NDC) Directory?
The NDC Directory is a database maintained by the FDA that contains information on finished, unfinished, and compounded drug products, including their NDC numbers, product types, and marketing dates.
How do I identify a drug using its NDC?
To identify a drug, use the FDA's National Drug Code Directory to find the proprietary name, non-proprietary name, and other relevant details associated with the NDC.
What factors affect the pricing of pharmaceutical drugs?
Pricing is affected by factors such as competition, regulatory changes, economic conditions, patient demand, and the introduction of generic versions.
Why are drug prices in the U.S. often higher than in other countries?
Drug prices in the U.S. are often higher due to a combination of factors including a drug mix that skews towards more expensive compounds and higher average prices per unit compared to other OECD countries and the rest of the world[3].
How do generic versions impact the market size and pricing of pharmaceutical drugs?
Generic versions can grow in sales but are unlikely to significantly impact the overall market size until 2025 for certain therapeutic classes. However, they can eventually reduce the pricing power of branded drugs.
Sources
- FDA's National Drug Code Directory - FDA
- Drug Price Trends for NDC 66758-0238 - DrugPatentWatch
- International Market Size and Prices - ASPE
- National Drug Code Database Background Information - FDA
- Missouri Specialty MAC Name of Drug - Missouri Department of Social Services
More… ↓
